7NWA image
Deposition Date 2021-03-16
Release Date 2022-11-02
Last Version Date 2024-01-31
Entry Detail
PDB ID:
7NWA
Keywords:
TRANSFERASE
Title:
CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC BRANCHED-CHAIN AMINOTRANSFERASE (BCAT1) IN COMPLEX WITH PLP AND COMPOUND A
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Escherichia coli BL21(DE3)
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.59 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
7NWA validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Branched-chain-amino-acid aminotransferase, cytosolic
Gene (Uniprot):BCAT1
Mutations:Ser379Arg
Chain IDs:A, B
Chain Length:389
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:P54687 Pfam ID:PF01063 EC:2.6.1.42
Ligand Molecules
MG
PLP
UTT
Primary Citation
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe.
J.Med.Chem. 65 14366 14390 (2022)
PMID: 36261130 DOI: 10.1021/acs.jmedchem.2c00441

Abstact

The branched-chain amino acid transaminases (BCATs) are enzymes that catalyze the first reaction of catabolism of the essential branched-chain amino acids to branched-chain keto acids to form glutamate. They are known to play a key role in different cancer types. Here, we report a new structural class of BCAT1/2 inhibitors, (trifluoromethyl)pyrimidinediones, identified by a high-throughput screening campaign and subsequent optimization guided by a series of X-ray crystal structures. Our potent dual BCAT1/2 inhibitor BAY-069 displays high cellular activity and very good selectivity. Along with a negative control (BAY-771), BAY-069 was donated as a chemical probe to the Structural Genomics Consortium.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
7NTR